106 related articles for article (PubMed ID: 21064134)
1. Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients.
Banyatsuppasin W; Butthep P; Atichartakarn V; Thakkinstian A; Archararit N; Pattanapanyasat K; Chuncharunee S
Am J Hematol; 2011 Jan; 86(1):89-92. PubMed ID: 21064134
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interferon-gamma in beta(o)-thalassemia/HbE and their clinical significance.
Wanachiwanawin W; Wiener E; Siripanyaphinyo U; Chinprasertsuk S; Mawas F; Fucharoen S; Wickramasinghe SN; Pootrakul P; Visudhiphan S
J Interferon Cytokine Res; 1999 Feb; 19(2):105-11. PubMed ID: 10090395
[TBL] [Abstract][Full Text] [Related]
3. Increase in spontaneous platelet aggregation in beta-thalassemia/hemoglobin E disease: a consequence of splenectomy.
Opartkiattikul N; Funahara Y; Fucharoen S; Talalak P
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():36-41. PubMed ID: 1298991
[TBL] [Abstract][Full Text] [Related]
4. Intravascular hemolysis, vascular endothelial cell activation and thrombophilia in splenectomized patients with hemoglobin E/β-thalassemia disease.
Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Aryurachai K
Acta Haematol; 2014; 132(1):100-7. PubMed ID: 24525823
[TBL] [Abstract][Full Text] [Related]
5. Interaction between endothelial cells and thalassemic red cells in vitro.
Butthep P; Bunyaratvej A; Kitaguchi H; Funahara Y; Fucharoen S
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():101-4. PubMed ID: 1298981
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of platelets from red cell fragments using laser technology: comparison between splenectomized and nonsplenectomized thalassemic patients.
Bunyaratvej A
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():250-2. PubMed ID: 7886588
[TBL] [Abstract][Full Text] [Related]
7. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients.
Atichartakarn V; Angchaisuksiri P; Aryurachai K; Onpun S; Chuncharunee S; Thakkinstian A; Atamasirikul K
Br J Haematol; 2002 Sep; 118(3):893-8. PubMed ID: 12181063
[TBL] [Abstract][Full Text] [Related]
8. Platelet activation and platelet-leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis.
Keawvichit R; Khowawisetsut L; Chaichompoo P; Polsrila K; Sukklad S; Sukapirom K; Khuhapinant A; Fucharoen S; Pattanapanyasat K
Ann Hematol; 2012 Nov; 91(11):1685-94. PubMed ID: 22847151
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell vesicles in thalassemia.
Lamchiagdhase P; Nitipongwanich R; Rattanapong C; Noulsri E; Lerdwana S; Pattanapanyasat K
J Med Assoc Thai; 2004 Mar; 87(3):233-8. PubMed ID: 15117038
[TBL] [Abstract][Full Text] [Related]
10. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia.
Butthep P; Rummavas S; Wisedpanichkij R; Jindadamrongwech S; Fucharoen S; Bunyaratvej A
Am J Hematol; 2002 Jun; 70(2):100-6. PubMed ID: 12111782
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic and thrombotic markers in patients with hemoglobin E/beta-thalassemia disease.
Angchaisuksiri P; Atichartakarn V; Aryurachai K; Archararit N; Chuncharunee S; Tiraganjana A; Rattanasiri S
Am J Hematol; 2007 Nov; 82(11):1001-4. PubMed ID: 17654509
[TBL] [Abstract][Full Text] [Related]
13. Morphological assessment of platelet activation in thalassemia.
Bunyaratvej A; Komanasin N; Sriurairatana S; Fucharoen S
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():60-4. PubMed ID: 1298995
[TBL] [Abstract][Full Text] [Related]
14. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
[TBL] [Abstract][Full Text] [Related]
15. Augmented TNF-alpha and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes.
Liese AM; Siddiqi MQ; Siegel JH; Denny T; Spolarics Z
J Leukoc Biol; 2001 Aug; 70(2):289-96. PubMed ID: 11493622
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin-bound platelets correlate with the increased platelet activity in hemoglobin E/β-thalassemia.
Chamchoi A; Srihirun S; Paiboonsukwong K; Sriwantana T; Kongkaew P; Fucharoen S; Pattanapanyasat K; Sibmooh N
Int J Lab Hematol; 2020 Oct; 42(5):518-525. PubMed ID: 32539231
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte-bearing ferritin in beta-thalassemia/Hb E.
Lamchaigdhase P; Pattanapanyasat K; Sritanaitipol A; Kuntamrongsri S; Fucharoen S
J Med Assoc Thai; 1992 Nov; 75(11):649-55. PubMed ID: 1307389
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease.
Atichartakarn V; Chuncharunee S; Archararit N; Udomsubpayakul U; Lee R; Tunhasiriwet A; Aryurachai K
Eur J Haematol; 2014 Apr; 92(4):346-53. PubMed ID: 24330103
[TBL] [Abstract][Full Text] [Related]
19. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta-thalassemia.
Helley D; Eldor A; Girot R; Ducrocq R; Guillin MC; Bezeaud A
Thromb Haemost; 1996 Sep; 76(3):322-7. PubMed ID: 8883264
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte phosphatidylserine exposure in β-thalassemia.
Ibrahim HA; Fouda MI; Yahya RS; Abousamra NK; Abd Elazim RA
Lab Hematol; 2014 Jun; 20(2):9-14. PubMed ID: 25000947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
